AngioDynamics, Inc.
ANGOHealthcareNASDAQMedical Instruments & Supplies · Last scanned Jul 18, 2026
Scan Results
Daily timeframeHeadquartered within the healthcare sector, AngioDynamics, Inc. focuses on Medical Instruments & Supplies services and products. AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. Valued at $558.4M, ANGO is a small-cap name in its sector. The company operates through Med Tech and Med Device segments.
Market Cap
$558.4M
Beta
0.34
P/E (TTM)
—
P/E (Fwd)
-300.22
EPS (TTM)
$-0.84
EPS (Fwd)
$-0.04
ROE
-20.8%
ROA
-5.1%
Cash
$53.9M
Total Debt
$11.0M
Free CF
$21.8M
52W Change
55.5%
Annual Financials
Cash vs Debt
The balance sheet looks solid with $53.9M in cash comfortably exceeding the $11.0M debt load. A net cash position generally provides financial flexibility during uncertain economic periods. The company generates $21.8M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at -20.8%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has been relatively flat, moving from $338.8M (2023) to $320.2M (2026).
The relatively low beta of 0.34 suggests ANGO is a less volatile holding compared to the broader index. The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing ANGO.